Transcriptomics

Dataset Information

0

PHD2/3-dependent hydroxylation of thyroid hormone receptor-α mediates the transcriptional regulation of phospholamban to tune the cardiac response to chronic β-adrenergic stress


ABSTRACT: Ischemic heart disease is the leading cause of heart failure. Both clinical trials and experimental animal studies demonstrate that chronic hypoxia can induce contractile dysfunction even before substantial ventricular damage, implicating a direct role of oxygen in the regulation of cardiac contractile function. Prolyl hydroxylase domain (PHD) proteins are well recognized as oxygen sensors and mediate a wide variety of cellular events by hydroxylating a growing list of protein substrates. Both PHD2 and 3 are highly expressed in the heart, yet their functional roles in modulating contractile function remain incompletely understood. Here, we report that combined deletion of PHD2 and 3 dramatically decreases the expression of phospholamban (PLN), results in sustained activation of CaMKII and sensitizes mice to myocardial injury induced by chronic β-adrenergic stress. We provide evidence that thyroid hormone receptor-α (TR-α), a transcriptional regulator of PLN, interacts with PHD2 and 3 and is hydroxylated at two proline residues. Inhibition of PHDs increases the interaction between TR-α and nuclear receptor co-repressor 2 (NCOR2) and suppresses PLN transcription. These observations provide new mechanistic insights into how oxygen directly modulates cardiac contractility, providing the possibility that cardiac function can be modulated therapeutically by tuning PHD enzymatic activity.

ORGANISM(S): Mus musculus

PROVIDER: GSE67726 | GEO | 2016/04/01

SECONDARY ACCESSION(S): PRJNA280758

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-04-01 | E-GEOD-67726 | biostudies-arrayexpress
2021-04-12 | PXD020175 | Pride
2021-06-11 | GSE151156 | GEO
2021-11-03 | PXD024594 | Pride
2021-07-22 | GSE168610 | GEO
2023-03-21 | MSV000091522 | MassIVE
2022-12-01 | GSE216536 | GEO
2024-07-17 | GSE239389 | GEO
2022-11-22 | GSE217921 | GEO
2021-07-27 | GSE173684 | GEO